Archive - April 2018
FDA Accepts New Drug Application for Duvelisib and Grants Priority Review
Unanimous Positive Result of FDA Advisory Committee Meeting for First Plant-Based Pharmaceutical Cannabidiol Treatment for Seizures in Patients with Two Rare, Severe Forms of Epilepsy
The Rise of Hazard Chemistry in Drug Development
The Digital Pharma Factory of Tomorrow
Will Shire agree to extend Takeda takeover talks?
AZ’s immuno-oncology combo fails another lung cancer trial
Sanofi appoints ex-Roche Reed as new R&D head
FDA panel undermines Lilly and Incyte’s baricitinib hopes